The	O
Epstein-Barr	B-protein
virus-encoded	I-protein
nuclear	I-protein
antigen	I-protein
EBNA-5	I-protein
accumulates	O
in	O
PML-containing	O
bodies	O
.	O

EBNA-5	B-protein
is	O
one	O
of	O
the	O
Epstein-Barr	B-protein
virus	I-protein
(	I-protein
EBV	I-protein
)	I-protein
-encoded	I-protein
nuclear	I-protein
proteins	I-protein
required	O
for	O
immortalization	O
of	O
human	B-cell_type
B	I-cell_type
lymphocytes	I-cell_type
.	O

In	O
the	O
nuclei	O
of	O
EBV-transformed	B-cell_line
lymphoblastoid	I-cell_line
cell	I-cell_line
lines	I-cell_line
EBNA-5	B-protein
is	O
preferentially	O
targetted	O
to	O
distinct	O
nuclear	O
foci	O
.	O

Previously	O
we	O
have	O
shown	O
(	O
W.Q.	O
Jiang	O
,	O
L.Szekely	O
,	O
V.Wendel-Hansen	O
,	O
N.Ringertz	O
,	O
G.Klein	O
,	O
and	O
A.	O
Rosen	O
,	O
Exp.Cell	O
Res	O
.	O

JournaL	NULL
or	NULL
VirRoLoGYy	NULL
,	NULL
Apr	NULL
.	NULL

1996	NULL
,	NULL
p.	NULL
2562-2568	NULL
0022-538	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

70	NULL
,	NULL
No	NULL
.	NULL

4	NULL
NOTES	NULL
The	NULL
Epstein-Barr	NULL
Virus-Encoded	NULL
Nuclear	NULL
Antigen	NULL
EBNA-5	NULL
Accumulates	NULL
in	NULL
PML-Containing	NULL
Bodies	NULL
LASZLO	NULL
SZEKELY	NULL
,	NULL
**	NULL
KATJA	NULL
POKROVSKAJA	NULL
,	NULL
'	NULL
WEI-QIN	NULL
JIANG	NULL
,	NULL
``	NULL
HUGUES	NULL
oz	NULL
THE	NULL
,	NULL
**	NULL
NILS	NULL
RINGERTZ	NULL
,	NULL
``	NULL
anp	NULL
GEORGE	NULL
KLEIN	NULL
!	NULL

Microbiology	NULL
and	NULL
Tumor	NULL
Biology	NULL
Center	NULL
'	NULL
and	NULL
Department	NULL
of	NULL
Cell	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
``	NULL
Karolinska	NULL
Institute	NULL
,	NULL
S	NULL
$	NULL
-171	NULL
77	NULL
Stockholm	NULL
,	NULL
Sweden	NULL
,	NULL
and	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
UPR	NULL
43	NULL
,	NULL
Hopital	NULL
St.	NULL
Louis	NULL
1	NULL
,	NULL
°	NULL
and	NULL
Service	NULL
de	NULL
Biochimie	NULL
,	NULL
``	NULL
75475	NULL
Paris	NULL
Cedex	NULL
10	NULL
,	NULL
France	NULL
Received	NULL
14	NULL
November	NULL
1995/Accepted	NULL
11	NULL
January	NULL
1996	NULL
EBNA-5	NULL
is	NULL
one	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-encoded	NULL
nuclear	NULL
proteins	NULL
required	NULL
for	NULL
immortalization	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

In	NULL
the	NULL
nuclei	NULL
of	NULL
EBV-transformed	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
EBNA-5	NULL
is	NULL
preferentially	NULL
targetted	NULL
to	NULL
distinct	NULL
nuclear	NULL
foci	NULL
.	NULL

Previously	NULL
we	NULL
have	NULL
shown	NULL
(	NULL
W.	NULL
Q.	NULL
Jiang	NULL
,	NULL
L.	NULL
Szekely	NULL
,	NULL
V.	NULL
Wendel-Hansen	NULL
,	NULL
N.	NULL
Ringertz	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
A.	NULL
Rosén	NULL
,	NULL
Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

197:314-318	NULL
,	NULL
1991	NULL
)	NULL
that	NULL
the	NULL
same	NULL
foci	NULL
also	NULL
contained	NULL
the	NULL
retinoblastoma	NULL
(	NULL
Rb	NULL
)	NULL
protein	NULL
.	NULL

Using	NULL
a	NULL
similar	NULL
double	NULL
immunofluorescence	NULL
technique	NULL
,	NULL
we	NULL
now	NULL
show	NULL
that	NULL
these	NULL
foci	NULL
colocalize	NULL
with	NULL
nuclear	NULL
bodies	NULL
positive	NULL
for	NULL
PML	NULL
,	NULL
the	NULL
promyelocytic	NULL
leukemia-associated	NULL
protein	NULL
.	NULL

Artificial	NULL
spreading	NULL
of	NULL
the	NULL
chromatin	NULL
by	NULL
exposure	NULL
to	NULL
the	NULL
forces	NULL
of	NULL
fluid	NULL
surface	NULL
tension	NULL
disrupts	NULL
this	NULL
colocalization	NULL
gradually	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
bodies	NULL
consist	NULL
of	NULL
at	NULL
least	NULL
two	NULL
subcomponents	NULL
.	NULL

Heat	NULL
shock	NULL
or	NULL
metabolic	NULL
stress	NULL
induced	NULL
by	NULL
high	NULL
cell	NULL
density	NULL
leads	NULL
to	NULL
the	NULL
release	NULL
of	NULL
EBNA-5	NULL
from	NULL
the	NULL
PML-positive	NULL
nuclear	NULL
bodies	NULL
and	NULL
induces	NULL
it	NULL
to	NULL
translocate	NULL
to	NULL
the	NULL
nucleoli	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
their	NULL
presence	NULL
in	NULL
nuclear	NULL
bodies	NULL
,	NULL
both	NULL
proteins	NULL
are	NULL
occasionally	NULL
present	NULL
in	NULL
nuclear	NULL
aggregates	NULL
and	NULL
doughnut-like	NULL
structures	NULL
in	NULL
which	NULL
PML	NULL
is	NULL
concentrated	NULL
in	NULL
an	NULL
outer	NULL
shell	NULL
.	NULL

Nuclear	NULL
bodies	NULL
with	NULL
prominent	NULL
PML	NULL
staining	NULL
are	NULL
seen	NULL
in	NULL
resting	NULL
B	NULL
lymphocytes	NULL
.	NULL

This	NULL
staining	NULL
pattern	NULL
does	NULL
not	NULL
change	NULL
upon	NULL
EBV	NULL
infection	NULL
.	NULL

In	NULL
freshly	NULL
infected	NULL
cells	NULL
EBNA-5	NULL
antigens	NULL
are	NULL
first	NULL
distributed	NULL
throughout	NULL
the	NULL
nucleoplasm	NULL
.	NULL

After	NULL
a	NULL
few	NULL
days	NULL
intensely	NULL
staining	NULL
foci	NULL
develop	NULL
.	NULL

These	NULL
foci	NULL
coincide	NULL
with	NULL
PML-positive	NULL
nuclear	NULL
bodies	NULL
.	NULL

At	NULL
a	NULL
later	NULL
stage	NULL
and	NULL
in	NULL
established	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
EBNA-5	NULL
is	NULL
almost	NULL
exclusively	NULL
present	NULL
in	NULL
the	NULL
PML-positive	NULL
nuclear	NULL
foci	NULL
.	NULL

The	NULL
colocalization	NULL
is	NULL
restricted	NULL
to	NULL
EBV-infected	NULL
human	NULL
lymphoblasts	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
indicate	NULL
that	NULL
the	NULL
distinct	NULL
EBNA-5	NULL
foci	NULL
are	NULL
not	NULL
newly	NULL
formed	NULL
structures	NULL
but	NULL
the	NULL
result	NULL
of	NULL
translocation	NULL
of	NULL
the	NULL
viral	NULL
protein	NULL
to	NULL
a	NULL
specialized	NULL
domain	NULL
present	NULL
already	NULL
in	NULL
the	NULL
nuclei	NULL
of	NULL
uninfected	NULL
cells	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-transformed	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
(	NULL
LCLs	NULL
)	NULL
express	NULL
six	NULL
nuclear	NULL
proteins	NULL
(	NULL
EBNA-1	NULL
to	NULL
-6	NULL
)	NULL
and	NULL
three	NULL
membrane	NULL
proteins	NULL
(	NULL
LMP1	NULL
,	NULL
2A	NULL
,	NULL
and	NULL
2B	NULL
)	NULL
.	NULL

Six	NULL
of	NULL
the	NULL
nine	NULL
proteins	NULL
,	NULL
including	NULL
the	NULL
protein	NULL
examined	NULL
in	NULL
the	NULL
present	NULL
study	NULL
,	NULL
EBNA-5	NULL
,	NULL
are	NULL
required	NULL
for	NULL
efficient	NULL
immortalization	NULL
(	NULL
5	NULL
,	NULL
20	NULL
,	NULL
32	NULL
)	NULL
.	NULL

Together	NULL
with	NULL
EBNA-2	NULL
,	NULL
EBNA-5	NULL
is	NULL
one	NULL
of	NULL
the	NULL
earliest	NULL
nuclear	NULL
proteins	NULL
expressed	NULL
in	NULL
EBV-infected	NULL
B	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

These	NULL
two	NULL
EBNAs	NULL
can	NULL
drive	NULL
the	NULL
resting	NULL
B	NULL
lymphocyte	NULL
,	NULL
the	NULL
prime	NULL
target	NULL
of	NULL
EBV	NULL
infection	NULL
,	NULL
into	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
of	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Levels	NULL
of	NULL
EBNA-5	NULL
expression	NULL
are	NULL
highest	NULL
during	NULL
the	NULL
first	NULL
days	NULL
of	NULL
EBV	NULL
infection	NULL
but	NULL
decline	NULL
later	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
freshly	NULL
infected	NULL
cells	NULL
,	NULL
EBNA-5	NULL
is	NULL
homogeneously	NULL
distributed	NULL
throughout	NULL
the	NULL
nucleoplasm	NULL
.	NULL

After	NULL
several	NULL
days	NULL
of	NULL
infection	NULL
EBNA-5	NULL
appears	NULL
in	NULL
distinct	NULL
nuclear	NULL
foci	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
established	NULL
LCLs	NULL
the	NULL
focal	NULL
pattern	NULL
dominates	NULL
.	NULL

The	NULL
homogeneous	NULL
nucleoplasmic	NULL
staining	NULL
decreases	NULL
or	NULL
disappears	NULL
completely	NULL
(	NULL
15	NULL
,	NULL
24	NULL
)	NULL
.	NULL

Previously	NULL
we	NULL
have	NULL
found	NULL
that	NULL
the	NULL
nuclear	NULL
foci	NULL
that	NULL
contain	NULL
EBNA-5	NULL
in	NULL
LCLs	NULL
also	NULL
contain	NULL
retinoblastoma	NULL
(	NULL
Rb	NULL
)	NULL
protein	NULL
(	NULL
14	NULL
)	NULL
.	NULL

We	NULL
also	NULL
demonstrated	NULL
that	NULL
EBNA-5	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
both	NULL
Rb	NULL
and	NULL
pS3	NULL
proteins	NULL
in	NULL
vitro	NULL
(	NULL
30	NULL
)	NULL
.	NULL

High-level	NULL
expression	NULL
of	NULL
EBNA-5	NULL
in	NULL
freshly	NULL
infected	NULL
B	NULL
cells	NULL
coincides	NULL
with	NULL
the	NULL
increased	NULL
transient	NULL
expression	NULL
of	NULL
p53	NULL
and	NULL
augmented	NULL
expression	NULL
of	NULL
Rb	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

The	NULL
nuclear	NULL
distribution	NULL
of	NULL
EBNA-5	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Phone	NULL
:	NULL
46	NULL
8	NULL
728	NULL
67	NULL
60	NULL
.	NULL

Fax	NULL
:	NULL
46	NULL
8	NULL
32	NULL
78	NULL
75	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
lassze	NULL
@	NULL
ki.se	NULL
.	NULL

2562	NULL
prompted	NULL
us	NULL
to	NULL
compare	NULL
its	NULL
immunofluorescence	NULL
staining	NULL
pattern	NULL
with	NULL
those	NULL
of	NULL
other	NULL
nuclear	NULL
proteins	NULL
showing	NULL
a	NULL
focal	NULL
expression	NULL
pattern	NULL
.	NULL

The	NULL
literature	NULL
contains	NULL
many	NULL
reports	NULL
of	NULL
such	NULL
patterns	NULL
and	NULL
of	NULL
nuclear	NULL
bodies	NULL
(	NULL
for	NULL
reviews	NULL
,	NULL
see	NULL
references	NULL
3	NULL
and	NULL
31	NULL
)	NULL
of	NULL
unknown	NULL
function	NULL
.	NULL

The	NULL
present	NULL
study	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
the	NULL
aim	NULL
of	NULL
examining	NULL
the	NULL
distribution	NULL
of	NULL
EBNA-5	NULL
in	NULL
relation	NULL
to	NULL
bodies	NULL
containing	NULL
the	NULL
PML	NULL
(	NULL
promyelocytic	NULL
leuke-mia-associated	NULL
)	NULL
protein	NULL
.	NULL

The	NULL
gene	NULL
encoding	NULL
the	NULL
PML	NULL
protein	NULL
was	NULL
identified	NULL
as	NULL
the	NULL
fusion	NULL
partner	NULL
of	NULL
retinoic	NULL
acid	NULL
receptor	NULL
«	NULL
in	NULL
the	NULL
t	NULL
(	NULL
15:17	NULL
)	NULL
trans-locations	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemias	NULL
(	NULL
7	NULL
,	NULL
16	NULL
)	NULL
.	NULL

The	NULL
PML	NULL
protein	NULL
preferentially	NULL
localized	NULL
to	NULL
distinct	NULL
nuclear	NULL
bodies	NULL
or	NULL
PODS	NULL
,	NULL
whereas	NULL
the	NULL
leukemia-associated	NULL
fusion	NULL
protein	NULL
is	NULL
distributed	NULL
in	NULL
a	NULL
micropunctated	NULL
fashion	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
acute	NULL
promyelocytic	NULL
leukemias	NULL
with	NULL
retinoic	NULL
acids	NULL
restores	NULL
the	NULL
punc-tated	NULL
staining	NULL
pattern	NULL
(	NULL
6	NULL
,	NULL
17	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Nuclear	NULL
bodies	NULL
,	NULL
corresponding	NULL
to	NULL
the	NULL
normal	NULL
PML	NULL
staining	NULL
pattern	NULL
,	NULL
were	NULL
already	NULL
identified	NULL
decades	NULL
ago	NULL
,	NULL
first	NULL
by	NULL
electron	NULL
microscopy	NULL
(	NULL
8	NULL
)	NULL
and	NULL
later	NULL
by	NULL
immunostaining	NULL
with	NULL
sera	NULL
from	NULL
patients	NULL
with	NULL
autoimmune	NULL
conditions	NULL
like	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Many	NULL
of	NULL
these	NULL
sera	NULL
react	NULL
with	NULL
PML	NULL
itself	NULL
.	NULL

Proteins	NULL
encoded	NULL
by	NULL
DNA	NULL
viruses	NULL
have	NULL
previously	NULL
been	NULL
found	NULL
to	NULL
accumulate	NULL
in	NULL
PML	NULL
bodies	NULL
.	NULL

The	NULL
ICPO	NULL
protein	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
,	NULL
which	NULL
contributes	NULL
to	NULL
the	NULL
initiation	NULL
of	NULL
the	NULL
immediate-early	NULL
viral	NULL
protein	NULL
cascade	NULL
(	NULL
21	NULL
,	NULL
23	NULL
)	NULL
,	NULL
is	NULL
targeted	NULL
to	NULL
the	NULL
PML-	NULL
and	NULL
$	NULL
p100-containing	NULL
nuclear	NULL
foci	NULL
.	NULL

Cotransfection	NULL
of	NULL
ICPO	NULL
with	NULL
ICP4	NULL
,	NULL
the	NULL
major	NULL
immediate-early	NULL
transcriptional	NULL
voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
NOTES	NULL
-	NULL
2563	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Colocalization	NULL
between	NULL
EBNA-5	NULL
(	NULL
green	NULL
)	NULL
and	NULL
PML	NULL
(	NULL
red	NULL
)	NULL
in	NULL
[	NULL
B4	NULL
nuclei	NULL
.	NULL

The	NULL
calculated	NULL
overlap	NULL
is	NULL
labelled	NULL
white	NULL
.	NULL

Bar	NULL
,	NULL
5	NULL
jm	NULL
.	NULL

regulator	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
,	NULL
has	NULL
led	NULL
to	NULL
the	NULL
entrapment	NULL
of	NULL
ICP4	NULL
in	NULL
the	NULL
ICPO-containing	NULL
bodies	NULL
(	NULL
23	NULL
)	NULL
.	NULL

Infection	NULL
with	NULL
adenoviruses	NULL
induces	NULL
an	NULL
extensive	NULL
redistribution	NULL
of	NULL
the	NULL
PML	NULL
from	NULL
the	NULL
spherical	NULL
nuclear	NULL
bodies	NULL
to	NULL
filamentous	NULL
structures	NULL
.	NULL

The	NULL
protein	NULL
encoded	NULL
by	NULL
E4-ORF3	NULL
is	NULL
responsible	NULL
for	NULL
this	NULL
reorganization	NULL
.	NULL

Furthermore	NULL
,	NULL
it	NULL
was	NULL
demonstrated	NULL
that	NULL
the	NULL
E1A	NULL
oncoprotein	NULL
of	NULL
adenovirus	NULL
concentrates	NULL
in	NULL
the	NULL
PML-positive	NULL
nuclear	NULL
bodies	NULL
(	NULL
4	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
EBNA-5	NULL
is	NULL
accumulated	NULL
in	NULL
the	NULL
PML-containing	NULL
bodies	NULL
both	NULL
in	NULL
freshly	NULL
infected	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
established	NULL
LCLs	NULL
but	NULL
disappears	NULL
from	NULL
these	NULL
structures	NULL
upon	NULL
heat	NULL
shock	NULL
or	NULL
metabolic	NULL
stress	NULL
or	NULL
during	NULL
chromatin	NULL
spreading	NULL
by	NULL
surface	NULL
tension	NULL
.	NULL

EBNA-5	NULL
and	NULL
PML	NULL
in	NULL
LCLs	NULL
.	NULL

In	NULL
order	NULL
to	NULL
establish	NULL
whether	NULL
the	NULL
EBNA-5	NULL
(	NULL
14	NULL
)	NULL
-and	NULL
PML-containing	NULL
nuclear	NULL
bodies	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
were	NULL
identical	NULL
,	NULL
lymphoblastoid	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
anti-EBNA-5	NULL
mouse	NULL
monoclonal	NULL
and	NULL
anti-PML	NULL
rabbit	NULL
polyclonal	NULL
antibodies	NULL
.	NULL

Immunofluorescent	NULL
staining	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
following	NULL
way	NULL
.	NULL

Cells	NULL
were	NULL
centrifuged	NULL
on	NULL
glass	NULL
slides	NULL
in	NULL
a	NULL
Cy-tospin	NULL
centrifuge	NULL
at	NULL
1,000	NULL
rpm	NULL
for	NULL
5	NULL
min	NULL
and	NULL
fixed	NULL
with	NULL
methanol-acetone	NULL
(	NULL
1:1	NULL
)	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
rehydrated	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
for	NULL
30	NULL
min	NULL
,	NULL
washed	NULL
in	NULL
balanced	NULL
salt	NULL
solution	NULL
,	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
antibodies	NULL
diluted	NULL
in	NULL
a	NULL
blocking	NULL
buffer	NULL
(	NULL
2	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
plus	NULL
0.02	NULL
%	NULL
NaN	NULL
,	NULL
in	NULL
balanced	NULL
salt	NULL
solution	NULL
)	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
washed	NULL
five	NULL
times	NULL
in	NULL
balanced	NULL
salt	NULL
solution	NULL
after	NULL
the	NULL
individual	NULL
incubation	NULL
steps	NULL
(	NULL
regularly	NULL
30	NULL
to	NULL
60	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
)	NULL
.	NULL

The	NULL
following	NULL
antibodies	NULL
were	NULL
used	NULL
:	NULL
JF186	NULL
,	NULL
anti-EBNA-5	NULL
mouse	NULL
monoclonal	NULL
antibody	NULL
(	NULL
11	NULL
)	NULL
,	NULL
anti-PML	NULL
rabbit	NULL
polyclonal	NULL
serum	NULL
(	NULL
6	NULL
)	NULL
,	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
Fab2	NULL
fragment	NULL
of	NULL
goat	NULL
anti-mouse	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
(	NULL
Pierce	NULL
)	NULL
,	NULL
and	NULL
Texas	NULL
red-conjugated	NULL
goat	NULL
anti-rabbit	NULL
Ig	NULL
(	NULL
Vector	NULL
)	NULL
.	NULL

The	NULL
secondary	NULL
conjugates	NULL
were	NULL
further	NULL
absorbed	NULL
onto	NULL
acetone-fixed	NULL
IB4	NULL
cells	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Double	NULL
fluorescence	NULL
stainings	NULL
of	NULL
EBNA-4	NULL
and	NULL
PML	NULL
were	NULL
carried	NULL
out	NULL
in	NULL
the	NULL
following	NULL
order	NULL
:	NULL
anti-EBNA-5	NULL
monoclonal	NULL
antibody	NULL
(	NULL
1:40	NULL
)	NULL
,	NULL
anti-PML	NULL
(	NULL
1:500	NULL
)	NULL
,	NULL
fluorescein	NULL
isothiocyanate-conjugated	NULL
anti-mouse	NULL
Ig	NULL
(	NULL
1:20	NULL
)	NULL
,	NULL
normal	NULL
mouse	NULL
serum	NULL
(	NULL
1:50	NULL
)	NULL
,	NULL
and	NULL
Texas	NULL
red-conjugated	NULL
anti-rabbit	NULL
Ig	NULL
(	NULL
1:30	NULL
)	NULL
.	NULL

The	NULL
cross-reactions	NULL
were	NULL
excluded	NULL
by	NULL
replacing	NULL
the	NULL
primary	NULL
antibodies	NULL
with	NULL
isotype-identical	NULL
anti-simian	NULL
virus	NULL
40	NULL
heat-labile	NULL
enterotoxin	NULL
monoclonal	NULL
antibody	NULL
and	NULL
normal	NULL
rabbit	NULL
serum	NULL
,	NULL
respectively	NULL
,	NULL
in	NULL
parallel	NULL
reactions	NULL
.	NULL

The	NULL
images	NULL
were	NULL
recorded	NULL
on	NULL
a	NULL
DAS	NULL
microscope	NULL
(	NULL
Leitz	NULL
DM	NULL
RB	NULL
)	NULL
with	NULL
a	NULL
Hamamatsu	NULL
dual-mode	NULL
cooled	NULL
charge-coupled	NULL
device	NULL
camera	NULL
(	NULL
C4880	NULL
)	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
Pentium	NULL
personal	NULL
computer	NULL
using	NULL
Image	NULL
Pro-Plus	NULL
(	NULL
Media	NULL
Cybernetics	NULL
)	NULL
and	NULL
Adobe	NULL
Photoshop	NULL
programs	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
studies	NULL
were	NULL
carried	NULL
out	NULL
on	NULL
1B4	NULL
cells	NULL
,	NULL
an	NULL
LCL	NULL
that	NULL
contains	NULL
one	NULL
integrated	NULL
copy	NULL
of	NULL
the	NULL
EBV	NULL
genome	NULL
and	NULL
uses	NULL
the	NULL
W	NULL
viral	NULL
promoter	NULL
to	NULL
initiate	NULL
the	NULL
giant	NULL
message	NULL
from	NULL
which	NULL
all	NULL
the	NULL
EBNAs	NULL
are	NULL
spliced	NULL
.	NULL

1B4	NULL
,	NULL
unlike	NULL
most	NULL
other	NULL
LCLs	NULL
,	NULL
expresses	NULL
high	NULL
levels	NULL
of	NULL
EBNA-5	NULL
.	NULL

In	NULL
[	NULL
B4	NULL
EBNA-5	NULL
is	NULL
localized	NULL
to	NULL
brilliantly	NULL
stained	NULL
nuclear	NULL
bodies	NULL
as	NULL
well	NULL
as	NULL
,	NULL
to	NULL
various	NULL
extents	NULL
,	NULL
to	NULL
homogeneously	NULL
stained	NULL
nucleoplasm	NULL
.	NULL

In	NULL
most	NULL
LCLs	NULL
EBNA-5	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
weakly	NULL
or	NULL
moderately	NULL
stained	NULL
nuclear	NULL
bodies	NULL
.	NULL

PML	NULL
staining	NULL
showed	NULL
no	NULL
difference	NULL
between	NULL
IB4	NULL
and	NULL
other	NULL
LCLs	NULL
.	NULL

It	NULL
detected	NULL
2	NULL
to	NULL
20	NULL
nuclear	NULL
bodies	NULL
,	NULL
whereas	NULL
the	NULL
nucleoplasm	NULL
remained	NULL
essentially	NULL
negative	NULL
.	NULL

Figure	NULL
1	NULL
shows	NULL
the	NULL
results	NULL
of	NULL
double	NULL
immunofluorescence	NULL
staining	NULL
and	NULL
digital	NULL
overlap	NULL
analysis	NULL
.	NULL

There	NULL
was	NULL
a	NULL
high	NULL
degree	NULL
of	NULL
colocalization	NULL
between	NULL
PML-	NULL
and	NULL
EBNA-5-positive	NULL
nuclear	NULL
bodies	NULL
in	NULL
interphase	NULL
IB4	NULL
.	NULL

Ninety-six	NULL
percent	NULL
of	NULL
the	NULL
nuclear	NULL
bodies	NULL
were	NULL
detectably	NULL
positive	NULL
for	NULL
both	NULL
proteins	NULL
.	NULL

A	NULL
similar	NULL
colocalization	NULL
was	NULL
found	NULL
in	NULL
two	NULL
other	NULL
LCLs	NULL
.	NULL

These	NULL
cell	NULL
lines	NULL
were	NULL
established	NULL
6	NULL
and	NULL
9	NULL
months	NULL
earlier	NULL
by	NULL
infecting	NULL
CD19-selected	NULL
peripheral	NULL
blood	NULL
B	NULL
cells	NULL
,	NULL
obtained	NULL
from	NULL
healthy	NULL
do-nors	NULL
,	NULL
with	NULL
B95-8	NULL
virus	NULL
.	NULL

The	NULL
two	NULL
colocalized	NULL
nuclear	NULL
proteins	NULL
,	NULL
EBNA-5	NULL
and	NULL
PML	NULL
,	NULL
were	NULL
usually	NULL
assembled	NULL
in	NULL
2	NULL
to	NULL
20	NULL
nuclear	NULL
dots	NULL
of	NULL
various	NULL
sizes	NULL
2564	NULL
NOTES	NULL
J.	NULL
ViroL	NULL
.	NULL

FIG	NULL
.	NULL

2	NULL
.	NULL

EBNA-5	NULL
(	NULL
A	NULL
and	NULL
D	NULL
;	NULL
green	NULL
)	NULL
,	NULL
PML	NULL
(	NULL
B	NULL
and	NULL
E	NULL
;	NULL
red	NULL
)	NULL
,	NULL
and	NULL
overlap	NULL
(	NULL
C	NULL
and	NULL
F	NULL
;	NULL
white	NULL
)	NULL
in	NULL
nuclear	NULL
aggregates	NULL
(	NULL
A	NULL
to	NULL
C	NULL
)	NULL
and	NULL
doughnut-like	NULL
structures	NULL
(	NULL
D	NULL
to	NULL
F	NULL
)	NULL
in	NULL
[	NULL
B4	NULL
cells	NULL
.	NULL

Bar	NULL
,	NULL
5	NULL
wm	NULL
.	NULL

and	NULL
shapes	NULL
.	NULL

In	NULL
most	NULL
cases	NULL
these	NULL
structures	NULL
were	NULL
spherical	NULL
,	NULL
but	NULL
occasionally	NULL
they	NULL
appeared	NULL
as	NULL
doughnut-like	NULL
structures	NULL
,	NULL
aggregates	NULL
of	NULL
nuclear	NULL
bodies	NULL
,	NULL
or	NULL
thread-like	NULL
structures	NULL
.	NULL

Although	NULL
the	NULL
locations	NULL
of	NULL
EBNA-5-	NULL
and	NULL
PML-positive	NULL
bodies	NULL
were	NULL
identical	NULL
,	NULL
the	NULL
relative	NULL
staining	NULL
intensities	NULL
of	NULL
EBNA-5	NULL
and	NULL
PML	NULL
in	NULL
individual	NULL
dots	NULL
varied	NULL
.	NULL

High-resolution	NULL
examination	NULL
of	NULL
the	NULL
larger	NULL
aggregates	NULL
and	NULL
the	NULL
doughnut-like	NULL
structures	NULL
showed	NULL
that	NULL
the	NULL
distribution	NULL
of	NULL
EBNA-5	NULL
within	NULL
these	NULL
bodies	NULL
might	NULL
be	NULL
quite	NULL
different	NULL
from	NULL
that	NULL
of	NULL
PML	NULL
.	NULL

PML	NULL
appeared	NULL
to	NULL
form	NULL
an	NULL
outer	NULL
shell	NULL
,	NULL
whereas	NULL
EBNA-5	NULL
was	NULL
located	NULL
inside	NULL
these	NULL
structures	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

PML	NULL
and	NULL
EBNA-5	NULL
in	NULL
spread	NULL
chromatin	NULL
.	NULL

In	NULL
order	NULL
to	NULL
study	NULL
the	NULL
relationship	NULL
between	NULL
the	NULL
two	NULL
colocalized	NULL
proteins	NULL
further	NULL
,	NULL
the	NULL
chromatin	NULL
was	NULL
spread	NULL
by	NULL
the	NULL
surface	NULL
tension	NULL
of	NULL
a	NULL
fluid	NULL
drop	NULL
with	NULL
rapidly	NULL
increasing	NULL
surface	NULL
area	NULL
,	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Schlammadinger	NULL
(	NULL
25	NULL
)	NULL
with	NULL
the	NULL
modification	NULL
that	NULL
prefixation	NULL
was	NULL
omitted	NULL
and	NULL
methanol-acetone	NULL
(	NULL
1:1	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
fixative	NULL
.	NULL

In	NULL
this	NULL
procedure	NULL
the	NULL
chromatin	NULL
forms	NULL
a	NULL
series	NULL
of	NULL
scaffold	NULL
structures	NULL
from	NULL
which	NULL
chromatin	NULL
loops	NULL
radiate	NULL
laterally	NULL
.	NULL

Double	NULL
immunofluorescence	NULL
staining	NULL
showed	NULL
that	NULL
the	NULL
PML-containing	NULL
bodies	NULL
did	NULL
not	NULL
change	NULL
their	NULL
size	NULL
or	NULL
shape	NULL
upon	NULL
chromatin	NULL
spreading	NULL
.	NULL

They	NULL
remained	NULL
preferentially	NULL
localized	NULL
within	NULL
the	NULL
area	NULL
of	NULL
the	NULL
nuclear	NULL
scaffold	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
EBNA-5-containing	NULL
dots	NULL
became	NULL
more	NULL
numerous	NULL
and	NULL
tended	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
more-peripheral	NULL
chromatin	NULL
loops	NULL
.	NULL

As	NULL
a	NULL
result	NULL
,	NULL
the	NULL
extent	NULL
of	NULL
colocalization	NULL
between	NULL
EBNA-5	NULL
and	NULL
PML	NULL
decreased	NULL
with	NULL
increasing	NULL
degrees	NULL
of	NULL
chromatin	NULL
spreading	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Heat	NULL
shock	NULL
disrupts	NULL
the	NULL
colocalization	NULL
between	NULL
EBNA-5	NULL
and	NULL
PML	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
heat	NULL
shock	NULL
or	NULL
metabolic	NULL
stress	NULL
induced	NULL
by	NULL
high	NULL
cell	NULL
density	NULL
causes	NULL
the	NULL
reversible	NULL
translocation	NULL
of	NULL
EBNA-5	NULL
to	NULL
the	NULL
nucleolus	NULL
in	NULL
1B4	NULL
and	NULL
other	NULL
cells	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Now	NULL
we	NULL
demonstrate	NULL
that	NULL
a	NULL
brief	NULL
heat	NULL
shock	NULL
(	NULL
30	NULL
min	NULL
at	NULL
45°C	NULL
)	NULL
leads	NULL
to	NULL
the	NULL
complete	NULL
dissociation	NULL
of	NULL
EBNA-5	NULL
from	NULL
the	NULL
PML	NULL
bodies	NULL
.	NULL

The	NULL
PML	NULL
bodies	NULL
remain	NULL
in	NULL
the	NULL
nucleoplasm	NULL
,	NULL
and	NULL
at	NULL
the	NULL
same	NULL
time	NULL
there	NULL
is	NULL
an	NULL
almost	NULL
complete	NULL
relocation	NULL
of	NULL
EBNA-5	NULL
into	NULL
the	NULL
nucleoli	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

EBNA-5	NULL
and	NULL
PML	NULL
dissociate	NULL
during	NULL
mitosis	NULL
.	NULL

The	NULL
number	NULL
and	NULL
the	NULL
staining	NULL
intensity	NULL
of	NULL
PML-positive	NULL
nuclear	NULL
bodies	NULL
vary	NULL
with	NULL
the	NULL
cell	NULL
cycle	NULL
(	NULL
18	NULL
)	NULL
.	NULL

We	NULL
found	NULL
that	NULL
all	NULL
interphase	NULL
nuclei	NULL
showed	NULL
colocalization	NULL
between	NULL
EBNA-5	NULL
and	NULL
PML	NULL
;	NULL
conse-quently	NULL
,	NULL
the	NULL
interphase	NULL
position	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
colocalization	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
proteins	NULL
dissociated	NULL
during	NULL
mitosis	NULL
.	NULL

PML	NULL
preferentially	NULL
accumulated	NULL
in	NULL
two	NULL
to	NULL
three	NULL
intensely	NULL
stained	NULL
conglomerates	NULL
within	NULL
the	NULL
area	NULL
of	NULL
the	NULL
mitotic	NULL
spindle	NULL
,	NULL
close	NULL
to	NULL
the	NULL
chromosomes	NULL
.	NULL

EBNA-5	NULL
was	NULL
distributed	NULL
diffusely	NULL
over	NULL
the	NULL
whole	NULL
cytoplasm	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

EBNA-5	NULL
and	NULL
PML	NULL
in	NULL
freshly	NULL
infected	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
freshly	NULL
infected	NULL
B	NULL
lymphocytes	NULL
EBNA-5	NULL
appears	NULL
as	NULL
early	NULL
as	NULL
12	NULL
h	NULL
postinfection	NULL
.	NULL

It	NULL
is	NULL
diffusely	NULL
distributed	NULL
in	NULL
the	NULL
whole	NULL
nucleoplasm	NULL
during	NULL
the	NULL
early	NULL
hours	NULL
but	NULL
starts	NULL
appearing	NULL
in	NULL
nuclear	NULL
bodies	NULL
as	NULL
well	NULL
by	NULL
the	NULL
end	NULL
of	NULL
the	NULL
first	NULL
day	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Uninfected	NULL
B	NULL
cells	NULL
contained	NULL
intensely	NULL
stained	NULL
PML-positive	NULL
nuclear	NULL
bodies	NULL
.	NULL

That	NULL
distribution	NULL
remained	NULL
unchanged	NULL
after	NULL
EBV	NULL
infection	NULL
.	NULL

The	NULL
nascent	NULL
EBNA-5	NULL
bodies	NULL
colocalized	NULL
with	NULL
the	NULL
PML-positive	NULL
structures	NULL
from	NULL
the	NULL
earliest	NULL
time	NULL
at	NULL
which	NULL
they	NULL
became	NULL
visible	NULL
.	NULL

Several	NULL
days	NULL
after	NULL
infection	NULL
,	NULL
the	NULL
EBNA-5	NULL
staining	NULL
became	NULL
completely	NULL
restricted	NULL
to	NULL
distinct	NULL
nuclear	NULL
dots	NULL
,	NULL
showing	NULL
perfect	NULL
overlap	NULL
with	NULL
the	NULL
PML-positive	NULL
bodies	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Colocalization	NULL
between	NULL
EBNA-5	NULL
and	NULL
PML	NULL
is	NULL
restricted	NULL
to	NULL
EBV-infected	NULL
human	NULL
B	NULL
lymphoblasts	NULL
.	NULL

Expression	NULL
of	NULL
EBNA-5	NULL
from	NULL
a	NULL
retrovirus-based	NULL
vector	NULL
in	NULL
CV1	NULL
monkey	NULL
kidney	NULL
epithe-lial	NULL
cells	NULL
,	NULL
SW480	NULL
human	NULL
colon	NULL
carcinoma	NULL
cells	NULL
,	NULL
and	NULL
Saos-2	NULL
human	NULL
osteosarcoma	NULL
cells	NULL
leads	NULL
to	NULL
the	NULL
accumulation	NULL
of	NULL
EBNA-5	NULL
in	NULL
the	NULL
nucleoplasm	NULL
in	NULL
an	NULL
almost	NULL
homogeneous	NULL
fashion	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
cells	NULL
(	NULL
around	NULL
20	NULL
%	NULL
)	NULL
also	NULL
Vou	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
NOTES	NULL
-	NULL
2565	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Disruption	NULL
of	NULL
colocalization	NULL
by	NULL
spreading	NULL
of	NULL
the	NULL
chromatin	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
colocalization	NULL
decreased	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
increase	NULL
in	NULL
the	NULL
extent	NULL
of	NULL
spreading	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
spreading	NULL
was	NULL
calculated	NULL
by	NULL
dividing	NULL
the	NULL
area	NULL
of	NULL
the	NULL
measured	NULL
object	NULL
by	NULL
the	NULL
area	NULL
of	NULL
an	NULL
average	NULL
unspread	NULL
nucleus	NULL
.	NULL

Moderate	NULL
spreading	NULL
(	NULL
4.8-fold	NULL
;	NULL
A	NULL
to	NULL
C	NULL
)	NULL
only	NULL
slightly	NULL
affected	NULL
the	NULL
colocalization	NULL
.	NULL

Further	NULL
spreading	NULL
(	NULL
5.2-fold	NULL
;	NULL
D	NULL
to	NULL
F	NULL
)	NULL
showed	NULL
clear	NULL
differences	NULL
in	NULL
the	NULL
staining	NULL
pattern	NULL
,	NULL
whereas	NULL
extensive	NULL
spreading	NULL
(	NULL
19-fold	NULL
;	NULL
G	NULL
to	NULL
I	NULL
)	NULL
led	NULL
to	NULL
the	NULL
dissociation	NULL
of	NULL
EBNA-5-	NULL
and	NULL
PML-positive	NULL
structures	NULL
.	NULL

EBNA-5	NULL
(	NULL
A	NULL
,	NULL
D	NULL
,	NULL
and	NULL
G	NULL
;	NULL
green	NULL
)	NULL
,	NULL
PML	NULL
(	NULL
B	NULL
,	NULL
E	NULL
,	NULL
and	NULL
H	NULL
;	NULL
red	NULL
)	NULL
,	NULL
overlap	NULL
(	NULL
C	NULL
,	NULL
F	NULL
,	NULL
and	NULL
I	NULL
;	NULL
white	NULL
)	NULL
,	NULL
and	NULL
DNA	NULL
(	NULL
blue	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Bar	NULL
,	NULL
5	NULL
m.	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Disruption	NULL
of	NULL
colocalization	NULL
by	NULL
30-min	NULL
heat	NULL
shock	NULL
.	NULL

PML	NULL
staining	NULL
(	NULL
A	NULL
)	NULL
,	NULL
a	NULL
phase-contrast	NULL
image	NULL
(	NULL
B	NULL
)	NULL
,	NULL
EBNA-5	NULL
staining	NULL
(	NULL
C	NULL
)	NULL
,	NULL
and	NULL
a	NULL
composite	NULL
image	NULL
of	NULL
EBNA-5	NULL
(	NULL
green	NULL
)	NULL
and	NULL
PML	NULL
(	NULL
red	NULL
)	NULL
in	NULL
1B4	NULL
nuclei	NULL
(	NULL
blue	NULL
)	NULL
(	NULL
D	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

A	NULL
three-color	NULL
overlap	NULL
image	NULL
of	NULL
PML	NULL
,	NULL
EBNA-5	NULL
,	NULL
and	NULL
DNA	NULL
of	NULL
a	NULL
single	NULL
nucleus	NULL
(	NULL
E	NULL
)	NULL
shows	NULL
that	NULL
upon	NULL
heat	NULL
shock	NULL
EBNA-5	NULL
is	NULL
dissociated	NULL
from	NULL
the	NULL
PML	NULL
bodies	NULL
and	NULL
accumulates	NULL
in	NULL
the	NULL
nucleolus	NULL
.	NULL

The	NULL
bar	NULL
in	NULL
panel	NULL
C	NULL
represents	NULL
20	NULL
um	NULL
(	NULL
scale	NULL
for	NULL
panels	NULL
A	NULL
to	NULL
D	NULL
)	NULL
,	NULL
and	NULL
that	NULL
in	NULL
panel	NULL
E	NULL
represents	NULL
5	NULL
wm	NULL
.	NULL

2566	NULL
NOTES	NULL
J.	NULL
ViroL	NULL
.	NULL

FIG	NULL
.	NULL

5	NULL
.	NULL

Dissociation	NULL
of	NULL
EBNA-5	NULL
and	NULL
PML	NULL
during	NULL
mitosis	NULL
.	NULL

The	NULL
colocalization	NULL
is	NULL
still	NULL
preserved	NULL
in	NULL
the	NULL
prophase	NULL
nucleus	NULL
(	NULL
A	NULL
to	NULL
C	NULL
)	NULL
;	NULL
however	NULL
,	NULL
a	NULL
cell	NULL
in	NULL
metaphase	NULL
(	NULL
D	NULL
to	NULL
F	NULL
;	NULL
arrow	NULL
in	NULL
panels	NULL
D	NULL
and	NULL
E	NULL
)	NULL
contains	NULL
PML	NULL
in	NULL
large	NULL
cytoplasmic	NULL
bodies	NULL
,	NULL
whereas	NULL
EBNA-5	NULL
is	NULL
homogeneously	NULL
distributed	NULL
all	NULL
over	NULL
the	NULL
cytoplasm	NULL
.	NULL

Neighboring	NULL
interphase	NULL
cells	NULL
show	NULL
perfect	NULL
colocalization	NULL
.	NULL

EBNA-5	NULL
(	NULL
A	NULL
and	NULL
D	NULL
;	NULL
green	NULL
)	NULL
,	NULL
PML	NULL
(	NULL
B	NULL
and	NULL
E	NULL
;	NULL
red	NULL
)	NULL
,	NULL
overlap	NULL
(	NULL
C	NULL
and	NULL
F	NULL
;	NULL
white	NULL
)	NULL
,	NULL
and	NULL
DNA	NULL
(	NULL
blue	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
bar	NULL
in	NULL
panel	NULL
A	NULL
represents	NULL
10	NULL
wm	NULL
(	NULL
scale	NULL
for	NULL
panels	NULL
A	NULL
to	NULL
C	NULL
)	NULL
,	NULL
and	NULL
that	NULL
in	NULL
panel	NULL
D	NULL
represents	NULL
5	NULL
jm	NULL
(	NULL
scale	NULL
for	NULL
panels	NULL
D	NULL
to	NULL
F	NULL
)	NULL
.	NULL

contain	NULL
brilliantly	NULL
stained	NULL
nuclear	NULL
bodies	NULL
that	NULL
contain	NULL
Hsp70	NULL
heat	NULL
shock	NULL
protein	NULL
as	NULL
well	NULL
(	NULL
29	NULL
)	NULL
.	NULL

All	NULL
of	NULL
these	NULL
cells	NULL
contained	NULL
PML	NULL
bodies	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
EBNA-S5-positive	NULL
foci	NULL
showed	NULL
no	NULL
colocalization	NULL
with	NULL
the	NULL
PML	NULL
bodies	NULL
in	NULL
any	NULL
of	NULL
the	NULL
transfec-tants	NULL
.	NULL

Moreover	NULL
,	NULL
EBNA-S5-transfected	NULL
EBV-negative	NULL
DG75	NULL
Burkitt	NULL
lymphoma	NULL
cells	NULL
,	NULL
which	NULL
express	NULL
EBNA-5	NULL
antigens	NULL
as	NULL
fine	NULL
speckled	NULL
nuclear	NULL
dots	NULL
,	NULL
failed	NULL
to	NULL
show	NULL
colocalization	NULL
with	NULL
PML	NULL
.	NULL

We	NULL
also	NULL
tested	NULL
the	NULL
virus-producing	NULL
cell	NULL
line	NULL
B95-8	NULL
,	NULL
a	NULL
marmoset	NULL
LCL	NULL
.	NULL

PML	NULL
showed	NULL
well-defined	NULL
nuclear	NULL
bodies	NULL
in	NULL
these	NULL
cells	NULL
,	NULL
whereas	NULL
EBNA-5	NULL
was	NULL
present	NULL
in	NULL
numerous	NULL
nuclear	NULL
dots	NULL
that	NULL
failed	NULL
to	NULL
colocalize	NULL
with	NULL
PML	NULL
.	NULL

The	NULL
PML-positive	NULL
nuclear	NULL
bodies	NULL
are	NULL
novel	NULL
organelles	NULL
that	NULL
contain	NULL
at	NULL
least	NULL
four	NULL
,	NULL
but	NULL
presumably	NULL
many	NULL
more	NULL
,	NULL
different	NULL
proteins	NULL
(	NULL
9	NULL
)	NULL
.	NULL

The	NULL
disruption	NULL
of	NULL
these	NULL
structures	NULL
in	NULL
promyelocytic	NULL
leukemias	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
PML-retinoic	NULL
acid	NULL
receptor	NULL
fusion	NULL
protein	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
cell	NULL
transformation	NULL
(	NULL
17	NULL
,	NULL
33	NULL
)	NULL
.	NULL

The	NULL
function	NULL
of	NULL
PML	NULL
and	NULL
these	NULL
nuclear	NULL
bodies	NULL
so	NULL
far	NULL
remains	NULL
unknown	NULL
.	NULL

Previous	NULL
reports	NULL
have	NULL
suggested	NULL
that	NULL
PML	NULL
bodies	NULL
play	NULL
a	NULL
role	NULL
in	NULL
host	NULL
cell	NULL
resistance	NULL
to	NULL
viral	NULL
infection	NULL
and/or	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
gene	NULL
expression	NULL
(	NULL
9	NULL
)	NULL
.	NULL

PML-containing	NULL
nuclear	NULL
bodies	NULL
appear	NULL
to	NULL
be	NULL
important	NULL
targets	NULL
of	NULL
interferon	NULL
response	NULL
.	NULL

Three	NULL
proteins	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
PML	NULL
,	NULL
$	NULL
p100	NULL
,	NULL
and	NULL
NDPS52	NULL
,	NULL
are	NULL
regulated	NULL
by	NULL
alfa	NULL
and	NULL
gamma	NULL
interferon	NULL
(	NULL
12	NULL
,	NULL
19	NULL
,	NULL
27	NULL
)	NULL
.	NULL

The	NULL
PML	NULL
protein	NULL
itself	NULL
may	NULL
act	NULL
as	NULL
a	NULL
tumor	NULL
suppressor	NULL
gene	NULL
product	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Lytic	NULL
infection	NULL
of	NULL
cells	NULL
by	NULL
DNA	NULL
viruses	NULL
like	NULL
herpes	NULL
simplex	NULL
virus	NULL
,	NULL
cytomegalovirus	NULL
,	NULL
and	NULL
adenovirus	NULL
leads	NULL
to	NULL
the	NULL
accumulation	NULL
of	NULL
viral	NULL
regulatory	NULL
proteins	NULL
in	NULL
the	NULL
PML-containing	NULL
nuclear	NULL
bodies	NULL
and	NULL
eventually	NULL
induces	NULL
redistribution	NULL
of	NULL
the	NULL
PML	NULL
protein	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Now	NULL
we	NULL
report	NULL
that	NULL
a	NULL
latency-associated	NULL
nuclear	NULL
protein	NULL
of	NULL
EBV	NULL
,	NULL
EBNA-5	NULL
,	NULL
also	NULL
accumulates	NULL
in	NULL
the	NULL
PML	NULL
bodies	NULL
at	NULL
the	NULL
early	NULL
phase	NULL
of	NULL
the	NULL
infection	NULL
and	NULL
persists	NULL
in	NULL
these	NULL
structures	NULL
in	NULL
established	NULL
LCLs	NULL
.	NULL

Unlike	NULL
the	NULL
lytic-phase-associated	NULL
proteins	NULL
of	NULL
other	NULL
viruses	NULL
,	NULL
however	NULL
,	NULL
EBNA-5	NULL
does	NULL
not	NULL
induce	NULL
morphological	NULL
changes	NULL
in	NULL
the	NULL
distribution	NULL
of	NULL
PML	NULL
.	NULL

Our	NULL
findings	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
previously	NULL
detected	NULL
EBNA-5-Rb-positive	NULL
blobs	NULL
are	NULL
not	NULL
newly	NULL
formed	NULL
structures	NULL
.	NULL

Rather	NULL
,	NULL
EBNA-5	NULL
accumulates	NULL
in	NULL
already-existing	NULL
nuclear	NULL
bodies	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
EBNA-5	NULL
positive	NULL
nuclear	NULL
bodies	NULL
in	NULL
different	NULL
transfected	NULL
cells	NULL
do	NULL
not	NULL
colocalize	NULL
with	NULL
PML	NULL
argues	NULL
that	NULL
other	NULL
cellular	NULL
and/or	NULL
viral	NULL
factors	NULL
that	NULL
are	NULL
present	NULL
only	NULL
in	NULL
EBV-infected	NULL
B	NULL
lymphoblasts	NULL
are	NULL
required	NULL
for	NULL
the	NULL
accumulation	NULL
of	NULL
EBNA-5	NULL
in	NULL
the	NULL
PML	NULL
bodies	NULL
.	NULL

Both	NULL
PML	NULL
and	NULL
EBNA-5	NULL
are	NULL
nuclear-matrix-associated	NULL
proteins	NULL
.	NULL

The	NULL
chromatin	NULL
spreading	NULL
experiments	NULL
suggest	NULL
that	NULL
the	NULL
two	NULL
proteins	NULL
associate	NULL
with	NULL
different	NULL
elements	NULL
of	NULL
the	NULL
matrix	NULL
.	NULL

voL	NULL
.	NULL

70	NULL
,	NULL
1996	NULL
NOTES	NULL
-	NULL
2567	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

EBNA-5	NULL
and	NULL
PML	NULL
in	NULL
EBV-infected	NULL
B	NULL
cells	NULL
after	NULL
72	NULL
h	NULL
(	NULL
A	NULL
to	NULL
C	NULL
)	NULL
and	NULL
8	NULL
days	NULL
(	NULL
D	NULL
to	NULL
F	NULL
)	NULL
.	NULL

EBNA-5	NULL
(	NULL
green	NULL
)	NULL
,	NULL
PML	NULL
(	NULL
red	NULL
)	NULL
,	NULL
and	NULL
overlap	NULL
(	NULL
white	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Each	NULL
bar	NULL
represents	NULL
5	NULL
pm	NULL
.	NULL

That	NULL
in	NULL
panel	NULL
A	NULL
applies	NULL
to	NULL
panels	NULL
A	NULL
to	NULL
C	NULL
,	NULL
and	NULL
that	NULL
in	NULL
panel	NULL
D	NULL
applies	NULL
to	NULL
panels	NULL
D	NULL
to	NULL
F.	NULL
The	NULL
PML	NULL
antigen	NULL
remains	NULL
on	NULL
the	NULL
scaffold	NULL
,	NULL
whereas	NULL
EBNA-5	NULL
is	NULL
spread	NULL
with	NULL
the	NULL
outpouring	NULL
chromatin	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
findings	NULL
,	NULL
along	NULL
with	NULL
the	NULL
differential	NULL
localization	NULL
patterns	NULL
of	NULL
the	NULL
two	NULL
proteins	NULL
in	NULL
the	NULL
doughnut-like	NULL
structures	NULL
,	NULL
we	NULL
propose	NULL
the	NULL
following	NULL
theory	NULL
.	NULL

PML	NULL
is	NULL
part	NULL
of	NULL
the	NULL
outer	NULL
shell	NULL
of	NULL
the	NULL
nuclear	NULL
body	NULL
,	NULL
firmly	NULL
anchored	NULL
to	NULL
the	NULL
nuclear	NULL
scaffold	NULL
.	NULL

EBNA-5	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
accumulates	NULL
inside	NULL
the	NULL
body	NULL
but	NULL
still	NULL
preserves	NULL
the	NULL
connection	NULL
to	NULL
elements	NULL
of	NULL
the	NULL
nuclear	NULL
matrix	NULL
that	NULL
are	NULL
linked	NULL
more	NULL
intimately	NULL
to	NULL
the	NULL
chromatin	NULL
than	NULL
to	NULL
the	NULL
rigid	NULL
scaffold	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
PHS	NULL
grant	NULL
2	NULL
RO1	NULL
CA14054-19	NULL
awarded	NULL
by	NULL
the	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Department	NULL
of	NULL
Health	NULL
and	NULL
Human	NULL
Services	NULL
,	NULL
and	NULL
grants	NULL
from	NULL
the	NULL
Swedish	NULL
Cancer	NULL
Society	NULL
(	NULL
Cancerfonden	NULL
)	NULL
,	NULL
the	NULL
Swedish	NULL
Medical	NULL
Research	NULL
Council	NULL
,	NULL
and	NULL
the	NULL
Concern	NULL
Foundation/	NULL
Cancer	NULL
Research	NULL
Institute	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Alfieri	NULL
,	NULL
C.	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1991	NULL
.	NULL

Early	NULL
events	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
infection	NULL
of	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Virology	NULL
181:595-608	NULL
.	NULL

(	NULL
Erratum	NULL
,	NULL
185:946	NULL
.	NULL
)	NULL

2	NULL
.	NULL

Allday	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
D.	NULL
H.	NULL
Crawford	NULL
,	NULL
and	NULL
B.	NULL
E.	NULL
Griffin	NULL
.	NULL

1989	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
latent	NULL
gene	NULL
expression	NULL
during	NULL
the	NULL
initiation	NULL
of	NULL
B	NULL
cell	NULL
immortalization	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

70:1755-1764	NULL
.	NULL

3	NULL
.	NULL

Brasch	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
R.	NULL
L.	NULL
Ochs	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
bodies	NULL
(	NULL
NBs	NULL
)	NULL
:	NULL
a	NULL
newly	NULL
``	NULL
rediscov-ered	NULL
``	NULL
organelle	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

202:211-223	NULL
.	NULL

4	NULL
.	NULL

Carvalho	NULL
,	NULL
T.	NULL
,	NULL
J.	NULL
S.	NULL
Seeler	NULL
,	NULL
K.	NULL
Obman	NULL
,	NULL
P.	NULL
Jordan	NULL
,	NULL
U.	NULL
Pettersson	NULL
,	NULL
G.	NULL
Akusjarvi	NULL
,	NULL
M.	NULL
Carmofonseca	NULL
,	NULL
and	NULL
A.	NULL
Dejean	NULL
.	NULL

1995	NULL
.	NULL

Targeting	NULL
of	NULL
adenovirus	NULL
Ela	NULL
and	NULL
E4-ORF3	NULL
proteins	NULL
to	NULL
nuclear	NULL
matrix-associated	NULL
PML	NULL
bodies	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

131:45-56	NULL
.	NULL

5	NULL
.	NULL

Cohen	NULL
,	NULL
J.	NULL
L	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
J.	NULL
Mannick	NULL
,	NULL
and	NULL
E.	NULL
Kief	NULL
.	NULL

1989	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
2	NULL
is	NULL
a	NULL
key	NULL
determinant	NULL
of	NULL
lymphocyte	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:9558-9562	NULL
.	NULL

6	NULL
.	NULL

Daniel	NULL
,	NULL
M.	NULL
T.	NULL
,	NULL
M.	NULL
Koken	NULL
,	NULL
O.	NULL
Romagne	NULL
,	NULL
S.	NULL
Barbey	NULL
,	NULL
A.	NULL
Bazarbachi	NULL
,	NULL
M.	NULL
Stadler	NULL
,	NULL
M.	NULL
C.	NULL
Guillemin	NULL
,	NULL
L.	NULL
Degos	NULL
,	NULL
C.	NULL
Chomienne	NULL
,	NULL
and	NULL
H.	NULL
de	NULL
The	NULL
.	NULL

1993	NULL
.	NULL

PML	NULL
protein	NULL
expression	NULL
in	NULL
hematopoictic	NULL
and	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
82:1858-1867	NULL
.	NULL

7.	NULL
de	NULL
The	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
Lavau	NULL
,	NULL
A.	NULL
Marchio	NULL
,	NULL
C.	NULL
Chomienne	NULL
,	NULL
L.	NULL
Degos	NULL
,	NULL
and	NULL
A.	NULL
Dejean	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
PML-RAR	NULL
alpha	NULL
fusion	NULL
mRNA	NULL
generated	NULL
by	NULL
the	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
encodes	NULL
a	NULL
functionally	NULL
altered	NULL
RAR	NULL
.	NULL

Coll	NULL
66:675-684.	NULL
.	NULL

de	NULL
The	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Riviere	NULL
,	NULL
and	NULL
W.	NULL
Bernhard	NULL
.	NULL

1960	NULL
.	NULL

Bull	NULL
.	NULL

Cancer	NULL
47:570-584	NULL
.	NULL

9	NULL
.	NULL

Dyck	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
G.	NULL
G.	NULL
Maul	NULL
,	NULL
W.	NULL
H.	NULL
Miller	NULL
,	NULL
Jr.	NULL
,	NULL
J.	NULL
D.	NULL
Chen	NULL
,	NULL
A.	NULL
Kakizuka	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Evans	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
novel	NULL
macromolecular	NULL
structure	NULL
is	NULL
a	NULL
target	NULL
of	NULL
the	NULL
promyelo-cyte-retinoic	NULL
acid	NULL
receptor	NULL
oncoprotein	NULL
.	NULL

Cell	NULL
76:333-343	NULL
.	NULL

10	NULL
.	NULL

Everett	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
Maul	NULL
.	NULL

1994	NULL
.	NULL

HSV-1	NULL
IE	NULL
protein	NULL
Vmw110	NULL
causes	NULL
redistribution	NULL
of	NULL
PML	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:5062-5069	NULL
.	NULL

11	NULL
.	NULL

Finke	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Rowe	NULL
,	NULL
B.	NULL
Kallin	NULL
,	NULL
I	NULL
.	NULL

A.	NULL
Rosen	NULL
,	NULL
J.	NULL
Dillner	NULL
,	NULL
and	NULL
G.	NULL
Klein	NULL
.	NULL

1987	NULL
.	NULL

Monoclonal	NULL
and	NULL
polyclonal	NULL
antibodies	NULL
against	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
antigen	NULL
5	NULL
(	NULL
EBNA-5	NULL
)	NULL
detect	NULL
multiple	NULL
protein	NULL
species	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
and	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

61:3870-3878	NULL
.	NULL

12	NULL
.	NULL

Guldner	NULL
,	NULL
H.	NULL
,	NULL
C.	NULL
Szostecki	NULL
,	NULL
T.	NULL
Gr	NULL
and	NULL
H.	NULL
Will	NULL
.	NULL

1992	NULL
.	NULL

IFN	NULL
enhances	NULL
expression	NULL
of	NULL
Sp100	NULL
,	NULL
an	NULL
autoantigen	NULL
in	NULL
primary	NULL
biliary	NULL
cirrhosis	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

149:4067-4073	NULL
.	NULL

13	NULL
.	NULL

Harlow	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
D.	NULL
Lane	NULL
.	NULL

(	NULL
ed	NULL
.	NULL
)	NULL

.	NULL

1988	NULL
.	NULL

Antibodies	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
14	NULL
.	NULL

Jiang	NULL
,	NULL
W.	NULL
Q.	NULL
,	NULL
L.	NULL
Szekely	NULL
,	NULL
V.	NULL
Wendel-Hansen	NULL
,	NULL
N.	NULL
Ringertz	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
A.	NULL
Rosén	NULL
.	NULL

1991	NULL
.	NULL

Co-localization	NULL
of	NULL
the	NULL
retinoblastoma	NULL
protein	NULL
and	NULL
the	NULL
Epstein-Barr	NULL
virus-encoded	NULL
nuclear	NULL
antigen	NULL
EBNA-5	NULL
.	NULL

Exp	NULL
.	NULL

Cell	NULL
Res	NULL
.	NULL

197:314-318	NULL
.	NULL

15	NULL
.	NULL

Jiang	NULL
,	NULL
W.	NULL
Q.	NULL
,	NULL
V.	NULL
Wendel-Hansen	NULL
,	NULL
A.	NULL
Lundkvist	NULL
,	NULL
N.	NULL
Ringertz	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
A.	NULL
Rosén	NULL
.	NULL

1991	NULL
.	NULL

Intranuclear	NULL
distribution	NULL
of	NULL
Epstein-Barr	NULL
virus-encoded	NULL
nuclear	NULL
antigens	NULL
EBNA-1	NULL
,	NULL
-2	NULL
,	NULL
-3	NULL
,	NULL
and	NULL
-5	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Sci	NULL
.	NULL

99:497-502.	NULL
go	NULL
2568	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

NOTES	NULL
Kakizuka	NULL
,	NULL
A.	NULL
,	NULL
W.	NULL
H.	NULL
Miller	NULL
,	NULL
Jr.	NULL
,	NULL
K.	NULL
Umesono	NULL
,	NULL
R.	NULL
P.	NULL
Warrell	NULL
,	NULL
Jr.	NULL
,	NULL
S.	NULL
R.	NULL
Frankel	NULL
,	NULL
V.	NULL
V.	NULL
Murty	NULL
,	NULL
E.	NULL
Dmitrovsky	NULL
,	NULL
and	NULL
R.	NULL
M.	NULL
Evans	NULL
.	NULL

1991	NULL
.	NULL

Chromosomal	NULL
translocation	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
in	NULL
human	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
fuses	NULL
RAR	NULL
alpha	NULL
with	NULL
a	NULL
novel	NULL
putative	NULL
transcription	NULL
factor	NULL
,	NULL
PML	NULL
.	NULL

Cell	NULL
66:663-674	NULL
.	NULL

Koken	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
F.	NULL
Puvion-Dutilleul	NULL
,	NULL
M.	NULL
C.	NULL
Guillemin	NULL
,	NULL
A.	NULL
Viron	NULL
,	NULL
G.	NULL
Linares-Cruz	NULL
,	NULL
N.	NULL
Stuurman	NULL
,	NULL
L.	NULL
de	NULL
Jong	NULL
,	NULL
C.	NULL
Szostecki	NULL
,	NULL
F.	NULL
Calvo	NULL
,	NULL
C.	NULL
Chomienne	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
t	NULL
(	NULL
15	NULL
;	NULL
17	NULL
)	NULL
translocation	NULL
alters	NULL
a	NULL
nuclear	NULL
body	NULL
in	NULL
a	NULL
retinoic	NULL
acid-reversible	NULL
fashion	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:1073-1083	NULL
.	NULL

Koken	NULL
,	NULL
M.	NULL
H.	NULL
M.	NULL
,	NULL
G.	NULL
Linares-Cruz	NULL
,	NULL
F.	NULL
Quignon	NULL
,	NULL
A.	NULL
Viron	NULL
,	NULL
M.	NULL
K.	NULL
Chelbi-Alix	NULL
,	NULL
J.	NULL
Sobczak-Thepot	NULL
,	NULL
L.	NULL
Juhlin	NULL
,	NULL
L.	NULL
Degos	NULL
,	NULL
F.	NULL
Calvo	NULL
,	NULL
and	NULL
H.	NULL
de	NULL
The	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
PML	NULL
growth-suppressor	NULL
has	NULL
altered	NULL
expression	NULL
in	NULL
human	NULL
oncogenesis	NULL
.	NULL

Oncogene	NULL
10:1315-1324	NULL
.	NULL

Korioth	NULL
,	NULL
F.	NULL
,	NULL
C.	NULL
Gieffers	NULL
,	NULL
G.	NULL
G.	NULL
Maul	NULL
,	NULL
and	NULL
J.	NULL
Frev	NULL
.	NULL

1995	NULL
.	NULL

Molecular	NULL
characterization	NULL
of	NULL
NDP52	NULL
,	NULL
a	NULL
novel	NULL
protein	NULL
of	NULL
the	NULL
nuclear	NULL
domain	NULL
10	NULL
,	NULL
which	NULL
is	NULL
redistributed	NULL
upon	NULL
virus	NULL
infection	NULL
and	NULL
interferon	NULL
treatment	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

130	NULL
:	NULL
1-13	NULL
.	NULL

Mannick	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
J.	NULL
I	NULL
Cohen	NULL
,	NULL
M.	NULL
Birkenbach	NULL
,	NULL
A.	NULL
Marchini	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
encoded	NULL
by	NULL
the	NULL
leader	NULL
of	NULL
the	NULL
EBNA	NULL
RNAs	NULL
is	NULL
important	NULL
in	NULL
B-lymphocyte	NULL
transformation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:6826-6837	NULL
.	NULL

Maul	NULL
,	NULL
G.	NULL
G.	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Everett	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
nuclear	NULL
location	NULL
of	NULL
PML	NULL
,	NULL
a	NULL
cellular	NULL
member	NULL
of	NULL
the	NULL
C3HC4	NULL
zinc-binding	NULL
domain	NULL
protein	NULL
family	NULL
,	NULL
is	NULL
rearranged	NULL
during	NULL
herpes	NULL
simplex	NULL
virus	NULL
infection	NULL
by	NULL
the	NULL
C3HC4	NULL
viral	NULL
protein	NULL
ICPO	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

75:1223-1233	NULL
.	NULL

Mu	NULL
,	NULL
Z.	NULL
M.	NULL
,	NULL
K.	NULL
V.	NULL
Chin	NULL
,	NULL
J.	NULL
H.	NULL
Liu	NULL
,	NULL
G.	NULL
Lozano	NULL
,	NULL
and	NULL
K.	NULL
S.	NULL
Chang	NULL
.	NULL

1994	NULL
.	NULL

PML	NULL
,	NULL
a	NULL
growth	NULL
suppressor	NULL
disrupted	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:6858-6867	NULL
.	NULL

Mullen	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
S.	NULL
Gerstberger	NULL
,	NULL
D.	NULL
M.	NULL
Ciufo	NULL
,	NULL
J.	NULL
D.	NULL
Mosca	NULL
,	NULL
and	NULL
G.	NULL
S.	NULL
Hayward	NULL
.	NULL

1995	NULL
.	NULL

Evaluation	NULL
of	NULL
colocalization	NULL
interactions	NULL
between	NULL
the	NULL
IE110	NULL
,	NULL
IE175	NULL
,	NULL
and	NULL
E63	NULL
transactivator	NULL
proteins	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
within	NULL
subcellular	NULL
punctate	NULL
structures	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:476-491	NULL
.	NULL

Petti	NULL
,	NULL
L.	NULL
,	NULL
C.	NULL
Sample	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1990	NULL
.	NULL

Subnuclear	NULL
localization	NULL
and	NULL
phos-	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

J.	NULL
ViroL	NULL
.	NULL

phorylation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
infection	NULL
nuclear	NULL
proteins	NULL
.	NULL

Virology	NULL
176:563-574	NULL
.	NULL

Schlammadinger	NULL
,	NULL
J	NULL
.	NULL

1990	NULL
.	NULL

Immunofluorescence	NULL
detection	NULL
of	NULL
nuclear	NULL
antigens	NULL
in	NULL
supramolecular	NULL
chromatin	NULL
spreads	NULL
.	NULL

Methods	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

1:235-241	NULL
.	NULL

Sinclair	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
I	NULL
Palmero	NULL
,	NULL
G.	NULL
Peters	NULL
,	NULL
and	NULL
P.	NULL
J.	NULL
Farrell	NULL
.	NULL

1994	NULL
.	NULL

EBNA-2	NULL
and	NULL
EBNA-LP	NULL
cooperate	NULL
to	NULL
cause	NULL
GO	NULL
to	NULL
G1	NULL
transition	NULL
during	NULL
immortalization	NULL
of	NULL
resting	NULL
human	NULL
B	NULL
lymphocytes	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:3321-3328	NULL
.	NULL

Stadler	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
K.	NULL
Chelbi-Alix	NULL
,	NULL
M.	NULL
H.	NULL
M.	NULL
Koken	NULL
,	NULL
L.	NULL
Venturini	NULL
,	NULL
C.	NULL
Lee	NULL
,	NULL
A.	NULL
Saib	NULL
,	NULL
F.	NULL
Quignon	NULL
,	NULL
L.	NULL
Pelicano	NULL
,	NULL
M.-C.	NULL
Guillemin	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
and	NULL
H.	NULL
de	NULL
The	NULL
.	NULL

Transcriptional	NULL
induction	NULL
of	NULL
the	NULL
PML	NULL
growth	NULL
suppressor	NULL
gene	NULL
by	NULL
interferons	NULL
is	NULL
mediated	NULL
through	NULL
an	NULL
ISRE	NULL
and	NULL
GAS	NULL
element	NULL
.	NULL

Oncogene	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Szekely	NULL
,	NULL
L.	NULL
,	NULL
W.-Q	NULL
.	NULL

Jiang	NULL
,	NULL
K.	NULL
Pokrovskaja	NULL
,	NULL
K.	NULL
G.	NULL
Wiman	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
N.	NULL
Ringertz	NULL
.	NULL

1995	NULL
.	NULL

Reversible	NULL
nucleolar	NULL
translocation	NULL
of	NULL
EBV	NULL
encoded	NULL
EBNA-5	NULL
and	NULL
Hsp70	NULL
proteins	NULL
after	NULL
exposure	NULL
to	NULL
heat	NULL
shock	NULL
or	NULL
cell	NULL
density	NULL
congestion	NULL
.	NULL

J.	NULL
Gen.	NULL
Virol	NULL
.	NULL

76:2423-2432	NULL
.	NULL

Szekely	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
Pokrovskaja	NULL
,	NULL
W.-Q	NULL
.	NULL

Jiang	NULL
,	NULL
G.	NULL
Selivanova	NULL
,	NULL
M.	NULL
Lowbeer	NULL
,	NULL
N.	NULL
Ringertz	NULL
,	NULL
K.	NULL
G.	NULL
Wiman	NULL
,	NULL
and	NULL
G.	NULL
Klein	NULL
.	NULL

1995	NULL
.	NULL

Resting	NULL
B-cells	NULL
,	NULL
EBV	NULL
infected	NULL
B-blasts	NULL
and	NULL
established	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
differ	NULL
in	NULL
their	NULL
Rb	NULL
,	NULL
p53	NULL
and	NULL
EBNA-5	NULL
expression	NULL
patterns	NULL
.	NULL

Oncogene	NULL
10:1869-1874	NULL
.	NULL

Szekely	NULL
,	NULL
L.	NULL
,	NULL
G.	NULL
Selivanova	NULL
,	NULL
K.	NULL
P.	NULL
Magnusson	NULL
,	NULL
G.	NULL
Klein	NULL
,	NULL
and	NULL
K.	NULL
G.	NULL
Wiman	NULL
.	NULL

1993	NULL
.	NULL

EBNA-5	NULL
,	NULL
an	NULL
Epstein-Barr	NULL
virus-encoded	NULL
nuclear	NULL
antigen	NULL
,	NULL
binds	NULL
to	NULL
the	NULL
retinoblastoma	NULL
and	NULL
p53	NULL
proteins	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:5455-5459	NULL
.	NULL

Thiry	NULL
,	NULL
M.	NULL
1995	NULL
.	NULL

Nucleic	NULL
acid	NULL
compartmentalization	NULL
within	NULL
the	NULL
cell	NULL
nucleus	NULL
by	NULL
in	NULL
situ	NULL
transferase-immunogold	NULL
techniques	NULL
.	NULL

Microscopy	NULL
Res	NULL
.	NULL

Tech	NULL
.	NULL

31:4-21	NULL
.	NULL

Tomkinson	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Robertson	NULL
,	NULL
and	NULL
E.	NULL
Kieff	NULL
.	NULL

1993	NULL
.	NULL

Epstein-Barr	NULL
virus	NULL
nuclear	NULL
proteins	NULL
EBNA-3A	NULL
and	NULL
EBNA-3C	NULL
are	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:2014-2025	NULL
.	NULL

Weis	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Rambaud	NULL
,	NULL
C.	NULL
Lavau	NULL
,	NULL
J.	NULL
Jansen	NULL
,	NULL
T.	NULL
Carvalho	NULL
,	NULL
M.	NULL
Carmo-Fonseca	NULL
,	NULL
A.	NULL
Lamond	NULL
,	NULL
and	NULL
A.	NULL
Dejean	NULL
.	NULL

1994	NULL
.	NULL

Retinoic	NULL
acid	NULL
regulates	NULL
aberrant	NULL
nuclear	NULL
localization	NULL
of	NULL
PML-RAR	NULL
alpha	NULL
in	NULL
acute	NULL
promyelocytic	NULL
leukemia	NULL
cells	NULL
.	NULL

Cell	NULL
76:345-356	NULL
.	NULL

